Reactions Weekly

, Volume 1203, Issue 1, pp 2–2 | Cite as

Tibotec warns of hepatotoxicity with darunavir

News item
  • 16 Downloads

Keywords

Hepatitis Ritonavir Immune Reconstitution Elevated Liver Enzyme Darunavir 

REFERENCE

  1. 1.
    Health Canada.Health Canada Endorsed Important Safety Information on PREZISTA (darunavir). Media Release: 12 May 2008. Available from: URL: http://www.hc-sc.gc.ca
  2. 2.
    Health Canada.PUBLIC COMMUNICATION Health Canada Endorsed Important Safety Information on PREZISTA (darunavir). Media Release: 12 May 2008. Available from: URL: http://www.hc.sc.ga.ca

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations